Research advances in mesenchymal stem cell-derived exosomes in treatment of brain injury.
- Author:
Yan YUE
1
;
Yi QU
;
De-Zhi MU
Author Information
1. Department of Pediatrics, West China Second Hospital, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China. mudz@scu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Apoptosis;
Brain Injuries;
therapy;
Exosomes;
physiology;
Humans;
Inflammation;
prevention & control;
Mesenchymal Stem Cell Transplantation;
Neovascularization, Physiologic;
T-Lymphocytes;
immunology
- From:
Chinese Journal of Contemporary Pediatrics
2017;19(12):1285-1290
- CountryChina
- Language:Chinese
-
Abstract:
Mesenchymal stem cell (MSC) transplantation is considered one of the most promising therapeutic strategies for the repair of brain injuries and plays an important role in various links of nerve repair. Recent studies have shown that MSC-derived exosomes may dominate the repair of brain injuries and help to promote angiogenesis, regulate immunity, inhibit apoptosis, and repair the nerves, and therefore, they have a great potential in the treatment of brain injuries in neonates. With reference to these studies, this article reviews the mechanism of action of exosomes in the repair of brain injuries and related prospects and challenges, in order to provide new directions for the treatment of brain injuries in neonates with stem cells.
